Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021

NEXT STORY
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Worldwide Point of Care (POC) Diagnostics Industry 2021 – Flexible Microfluidics to Enable Real-time Assessment of Health
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mateon Therapeutics Reports Second Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), ...

author_avatar
NASDAQ Market News

GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School

author_avatar
NASDAQ Market News

Sarepta Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors

- Gray Recognized for Scientific and Financial Acumen as Board Leader -CAMBRIDGE, Mass., Dec. ...

author_avatar
NASDAQ Market News